plenti-FLAG-CAMK2D Citations (1)

Originally described in: CAMK2D serves as a molecular scaffold for RNF8-MAD2 complex to induce mitotic checkpoint in glioma.
Chuah YH, Tay EXY, Grinchuk OV, Yoon J, Feng J, Kannan S, Robert M, Jakhar R, Liang Y, Lee BWL, Wang LC, Lim YT, Zhao T, Sobota RM, Lu G, Low BC, Crasta KC, Verma CS, Lin Z, Ong DST Cell Death Differ. 2023 Aug;30(8):1973-1987. doi: 10.1038/s41418-023-01192-3. Epub 2023 Jul 19. PubMed Journal

---

Articles Citing plenti-FLAG-CAMK2D

Articles
H3 dopaminylation and CaMKII modulate diffuse midline glioma response to CDK9 inhibition. Murdaugh RL, Eberl BR, Richard RU, Campos-Hensley EI, Nnyagu AN, Elam WA, Tsao AN, Tremblay JR, Ma R, Dei-Ampeh AK, Pham K, Kraushaar DC, Yu K, Olson CM, Serin-Harmanci A, Deneen B, Anastas JN. bioRxiv [Preprint]. 2026 Apr 10:2026.04.07.714507. doi: 10.64898/2026.04.07.714507. PubMed

If you have published an article using this material, please email us at to have your article added to this page.